Fielder Capital Group LLC Decreases Stake in CME Group Inc. (NASDAQ:CME)

Key Points

• Fielder Capital Group LLC reduced its stake in CME Group Inc. by 45.4% in the first quarter, holding just 1,348 shares valued at $358,000.
• CME Group reported earnings of $2.96 per share, exceeding estimates by $0.05, and had a 10.4% year-over-year revenue increase to $1.69 billion.
• The company issued a quarterly dividend of $1.25, translating to an annualized yield of 1.79% with a payout ratio of 48.40%.

Fielder Capital Group LLC lessened its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 45.4% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,348 shares of the financial services provider's stock after selling 1,121 shares during the quarter. Fielder Capital Group LLC's holdings in CME Group were worth $358,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. SeaCrest Wealth Management LLC boosted its stake in shares of CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after buying an additional 40 shares during the period. New Age Alpha Advisors LLC raised its position in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares in the last quarter. OneAscent Financial Services LLC raised its position in shares of CME Group by 4.0% during the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock worth $293,000 after acquiring an additional 43 shares in the last quarter. Ballentine Partners LLC raised its position in shares of CME Group by 0.8% during the 1st quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock worth $1,546,000 after acquiring an additional 45 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC raised its position in shares of CME Group by 3.6% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after acquiring an additional 47 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Trading Up 0.9%

Shares of CME stock opened at $279.55 on Monday. The business's 50 day moving average is $276.44 and its two-hundred day moving average is $262.72. CME Group Inc. has a twelve month low of $193.25 and a twelve month high of $290.79. The company has a market capitalization of $100.74 billion, a P/E ratio of 27.06, a price-to-earnings-growth ratio of 4.96 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the business posted $2.56 EPS. The company's revenue was up 10.4% on a year-over-year basis. Equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.79%. CME Group's dividend payout ratio (DPR) is currently 48.40%.

Insider Buying and Selling

In other CME Group news, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $277.88, for a total value of $294,552.80. Following the transaction, the director directly owned 3,108 shares in the company, valued at approximately $863,651.04. This trade represents a 25.43% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the sale, the director owned 3,668 shares in the company, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,400 shares of company stock worth $3,152,410. 0.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on CME shares. UBS Group reissued a "neutral" rating and set a $305.00 target price on shares of CME Group in a research report on Thursday. Barclays cut their target price on CME Group from $299.00 to $298.00 and set an "equal weight" rating on the stock in a research report on Thursday. Royal Bank Of Canada reissued a "sector perform" rating and set a $269.00 target price on shares of CME Group in a research report on Thursday, April 3rd. Piper Sandler raised their target price on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Finally, Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, CME Group presently has an average rating of "Hold" and an average price target of $261.93.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.